ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,815,000 | +109.2% | 406,100 | +10.1% | 0.02% | +100.0% |
| Q1 2019 | $8,994,000 | +76.7% | 368,900 | +3.3% | 0.01% | +42.9% |
| Q4 2018 | $5,089,000 | -4.1% | 357,100 | +2.3% | 0.01% | +16.7% |
| Q3 2018 | $5,305,000 | -7.9% | 349,000 | +1.6% | 0.01% | -14.3% |
| Q2 2018 | $5,762,000 | +8.4% | 343,400 | +5.5% | 0.01% | +16.7% |
| Q1 2018 | $5,314,000 | +34.5% | 325,600 | +5.5% | 0.01% | +50.0% |
| Q4 2017 | $3,951,000 | +6.2% | 308,700 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $3,720,000 | +66.2% | 302,400 | +13.1% | 0.00% | +33.3% |
| Q2 2017 | $2,238,000 | +0.1% | 267,400 | +7.0% | 0.00% | 0.0% |
| Q1 2017 | $2,235,000 | +5.2% | 250,000 | +3.4% | 0.00% | 0.0% |
| Q4 2016 | $2,125,000 | +23.1% | 241,800 | -5.4% | 0.00% | 0.0% |
| Q3 2016 | $1,726,000 | +128.9% | 255,700 | +20.8% | 0.00% | +200.0% |
| Q2 2016 | $754,000 | +12.7% | 211,700 | -9.8% | 0.00% | 0.0% |
| Q1 2016 | $669,000 | -17.1% | 234,800 | +22.8% | 0.00% | -50.0% |
| Q4 2015 | $807,000 | -7.5% | 191,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $872,000 | -27.3% | 191,200 | +15.0% | 0.00% | -33.3% |
| Q2 2015 | $1,199,000 | +13.0% | 166,300 | +15.5% | 0.00% | 0.0% |
| Q1 2015 | $1,061,000 | +55.8% | 144,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $681,000 | +38.4% | 144,000 | +4.6% | 0.00% | +50.0% |
| Q3 2014 | $492,000 | -21.7% | 137,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $628,000 | -2.9% | 137,700 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $647,000 | +18.1% | 137,700 | +25.9% | 0.00% | +50.0% |
| Q4 2013 | $548,000 | -19.4% | 109,400 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $680,000 | +31.5% | 109,400 | -3.9% | 0.00% | +50.0% |
| Q2 2013 | $517,000 | – | 113,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |